Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial.
Atherogenic indices
Calcium
Non-alcoholic fatty liver
Supplementation
Vitamin D
Journal
Iranian journal of pharmaceutical research : IJPR
ISSN: 1735-0328
Titre abrégé: Iran J Pharm Res
Pays: Netherlands
ID NLM: 101208407
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
16
5
2019
pubmed:
16
5
2019
medline:
16
5
2019
Statut:
ppublish
Résumé
The role of non-alcoholic fatty liver disease (NAFLD) as a potential independent cardiovascular disease (CVD) risk factor has recently gained considerable attention because CVD is the common cause of death in NAFLD patients. We aimed to estimate the effects of vitamin D supplementation alone or in combination with calcium on atherogenic indices, liver function tests, and grade of disease in patients with NAFLD. One-hundred twenty NAFLD patients were randomized in a double-blind, placebo-controlled clinical trial as follows: D (1000 IU vitamin D), CaD (500 mg as calcium carbonate plus 1000 IU vitamin D) or P (placebo), once daily with meals over 12 weeks. Adjusted for all the baseline measures, reduction in serum ALT, AST, LDL-C/HDL-C, TC/HDL-C, and non-HDL-C were significantly higher in the CaD compared with the P group (
Types de publication
Journal Article
Langues
eng
Pagination
496-505Références
J Clin Lipidol. 2013 Jan-Feb;7(1):65-81
pubmed: 23351585
J Mol Med (Berl). 2002 Dec;80(12):753-69
pubmed: 12483461
J Clin Invest. 2006 May;116(5):1435-42
pubmed: 16670775
Am J Cardiol. 2009 Jun 15;103(12):1716-20
pubmed: 19539081
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Acta Med Okayama. 2013;67(1):45-53
pubmed: 23439508
Diabetes Res Clin Pract. 2012 Apr;96(1):47-52
pubmed: 22189171
Ann Epidemiol. 2013 Sep;23(9):564-70
pubmed: 23958407
Hypertension. 2008 Nov;52(5):847-55
pubmed: 18824662
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2321-6
pubmed: 22814750
Arch Iran Med. 2016 Sep;19(9):631-8
pubmed: 27631178
EJIFCC. 2010 Oct 29;21(3):64-7
pubmed: 27683375
J Hypertens. 1998 Nov;16(11):1693-9
pubmed: 9856371
Int J Clin Pract. 2010 Apr;64(5):544-57
pubmed: 20456209
Diabetes Care. 2005 Aug;28(8):1916-21
pubmed: 16043732
Pediatr Diabetes. 2008 Oct;9(5):464-71
pubmed: 18507788
PLoS One. 2015 Jul 15;10(7):e0131938
pubmed: 26176958
Clin Nutr. 2017 Dec;36(6):1490-1497
pubmed: 27720403
PLoS One. 2014 Feb 21;9(2):e89721
pubmed: 24586986
Circulation. 2008 Sep 30;118(14):1476-85
pubmed: 18824654
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
BMJ. 2008 Feb 2;336(7638):262-6
pubmed: 18198394
Circulation. 2013 Dec 3;128(23):2517-31
pubmed: 24297817
Clin Nutr. 2015 Jun;34(3):484-9
pubmed: 24953770
J Pediatr. 2004 Oct;145(4):445-51
pubmed: 15480365
PLoS One. 2016 Oct 26;11(10):e0165324
pubmed: 27783655
Hepatology. 2012 Jan;55(1):331
pubmed: 21969091
Am J Cardiol. 2005 Aug 1;96(3):399-404
pubmed: 16054467
Diabetes Metab Res Rev. 2008 Sep;24(6):459-64
pubmed: 18551686
World J Gastroenterol. 2014 Jul 14;20(26):8407-15
pubmed: 25024598
J Am Coll Cardiol. 2009 Jan 27;53(4):316-22
pubmed: 19161879
Int J Cardiol. 2013 Oct 30;169(2):106-11
pubmed: 24035175
Curr Treat Options Cardiovasc Med. 2012 Aug;14(4):414-24
pubmed: 22689009
Obes Surg. 2010 Dec;20(12):1698-709
pubmed: 20473581
Prim Care Diabetes. 2010 Oct;4(3):129-37
pubmed: 20299294
Medicine (Baltimore). 2016 Feb;95(8):e2774
pubmed: 26937904
Diabetes Care. 2009 Jul;32(7):1278-83
pubmed: 19366976
Pediatr Res. 2010 Jun;67(6):665-70
pubmed: 20496475
Diabetes Res Clin Pract. 2015 Aug;109(2):440-9
pubmed: 25944538
Atherosclerosis. 2009 Jan;202(1):289-95
pubmed: 18452924
Curr Atheroscler Rep. 2013 Nov;15(11):362
pubmed: 24022513